In tumor models that were unresponsive to ICIs combined with anti-PD-1 antibodies or anti-CTLA4 antibodies alone, it was further confirmed that intratumoral injection of an oncolytic bovine poxvirus encoding IL-7 and IL-12 combined with ICI therapy improved anti-tumor activity (77). This evidence concerns the gene CTLA4 and neoplasm.